Christophe Rousselle
14 Rue Pierre Et Marie Curie
Maisons-les-soulaines, 94701, France
Maisons-les-soulaines, 94701, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
SCCS opinion on biphenyl-2-ol and sodium 2-biphenylolate used in cosmetic products (CAS/EC No. 90-43-7/201-993-5 and 132-27-4/205-055-6)- SCCS/1669/24.
Journal: NAM journal
Published: June 29, 2026
Modelling the regulatory toxicology system to promote the effective use of new approach methodologies: a system thinking approach.
Journal: NAM journal
Published: June 05, 2026
Erratum to "Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new Biomarkers into OECD test Guidelines" [Regul. Toxicol. Pharm.(167) 106041].
Journal: Regulatory toxicology and pharmacology : RTP
Published: May 20, 2026
Pineal Region Tumors: Clinical Symptoms and Syndromes.
Journal: Advances and technical standards in neurosurgery
Published: May 11, 2026
The way forward for assessing the human health safety of cosmetics in the EU: Proceedings of Workshop 2.
Journal: Archives of toxicology
Published: November 27, 2025
Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines.
Journal: Regulatory toxicology and pharmacology : RTP
Published: September 01, 2025
Exploring experiences of the regulatory toxicology system: system-level promoters and inhibitors of new approach methodologies.
Journal: Archives of toxicology
Published: June 09, 2025
Introducing the OECD guidance document on occupational biomonitoring: A harmonized methodology for deriving occupational biomonitoring levels (OBL).
Journal: Toxicology letters
Published: August 04, 2024
Time for CHANGE: system-level interventions for bringing forward the date of effective use of NAMs in regulatory toxicology.
Journal: Archives of toxicology
Published: May 15, 2024
Last Updated: 09/26/2026